|
|
Accelerator Corporation, founded in 2003, is a privately-held biotechnology investment and development company located in Seattle and New York. Resources provided by Accelerator and its Affiliates - MPM Capital, ARCH Venture Partners, Alexandria Real Estate Equities, Inc., Versant Ventures, Amgen Ventures, OVP Venture Partners, and the Institute for Systems Biology - include committed investment capital, state-of-the-art facilities, world-class scientific and technical expertise and support, and experienced start-up management. Accelerator occupies an 18,000 square foot state-of-the-art space located within a 165,000 SF facility owned and developed by an affiliate of Alexandria Real Estate Equities, Inc. in the midst of the vibrant Eastlake life science cluster in Seattle. The facility includes a number of laboratory/office 'suites' as well as common space (reception, conference rooms, break room, etc.) and support infrastructure (autoclave/glass wash, DI water system, telecommunications/network, etc.). In the past nine years, twelve companies have been invested in through Accelerator. Five have emerged and raised follow on financings of more than $164 million. Three remain under management at Accelerator. In all, Accelerator companies have raised in excess of $221 million in initial and follow-on financings. Accelerator's investors have committed an additional $22.5 million to enable Accelerator to continue to identify, capitalize, and develop the next-generation of exciting emerging biotechnologies. In July of 2014, the firm announced the closing of Accelerator IV with $51.1 million in capital commitments.
|
